Norges Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8B Buy
+11,471,413
New +$11.7B 1.37% 11
2026
Q1
Sell
-12,074,882
Closed -$13B 778
2025
Q4
$13B Buy
+12,074,882
New +$11.5B 1.39% 10
2025
Q3
Sell
-11,324,406
Closed -$8.83B 869
2025
Q2
$8.83B Buy
11,324,406
+329,060
+3% +$256M 1.1% 10
2025
Q1
$9.08B Buy
10,995,346
+104,274
+1% +$86.8M 1.27% 8
2024
Q4
$8.41B Buy
10,891,072
+404,043
+4% +$335M 1.1% 9
2024
Q3
$9.29B Sell
10,487,029
-517,823
-5% -$466M 1.3% 8
2024
Q2
$9.96B Buy
11,004,852
+288,833
+3% +$231M 1.49% 7
2024
Q1
$8.34B Buy
10,716,019
+435,209
+4% +$310M 1.32% 7
2023
Q4
$5.99B Buy
10,280,810
+410,631
+4% +$240M 1.05% 10
2023
Q3
$5.3B Buy
9,870,179
+22,477
+0.2% +$11.6M 1.08% 9
2023
Q2
$4.62B Buy
9,847,702
+198,793
+2% +$83.4M 0.91% 11
2023
Q1
$3.31B Buy
9,648,909
+310,931
+3% +$105M 0.73% 18
2022
Q4
$3.42B Buy
9,337,978
+772,612
+9% +$274M 0.82% 15
2022
Q3
$2.77B Buy
8,565,366
+268,640
+3% +$85.1M 0.74% 17
2022
Q2
$2.69B Buy
8,296,726
+181,638
+2% +$54.5M 0.7% 21
2022
Q1
$2.32B Buy
8,115,088
+100,588
+1% +$25.9M 0.51% 33
2021
Q4
$2.21B Sell
8,014,500
-246,196
-3% -$62.4M 0.46% 42
2021
Q3
$1.91B Sell
8,260,696
-254,465
-3% -$62.8M 0.42% 42
2021
Q2
$1.95B Sell
8,515,161
-271,619
-3% -$54.6M 0.42% 43
2021
Q1
$1.64B Buy
8,786,780
+120,037
+1% +$23.5M 0.38% 51
2020
Q4
$1.46B Buy
8,666,743
+28,940
+0.3% +$4.32M 0.34% 58
2020
Q3
$1.28B Buy
8,637,803
+280,568
+3% +$43.4M 0.34% 59
2020
Q2
$1.37B Sell
8,357,235
-454,108
-5% -$69.7M 0.4% 49
2020
Q1
$1.22B Sell
8,811,343
-102,215
-1% -$14M 0.44% 43
2019
Q4
$1.17B Hold
8,913,558
0.33% 58
2019
Q3
$997M Sell
8,913,558
-55,104
-0.6% -$6.13M 0.31% 61
2019
Q2
$994M Buy
8,968,662
+52,083
+0.6% +$6.13M 0.31% 62
2019
Q1
$1.16B Sell
8,916,579
-209,643
-2% -$25.5M 0.37% 47
2018
Q4
$1.06B Buy
9,126,222
+44,563
+0.5% +$4.98M 0.39% 47
2018
Q3
$975M Hold
9,081,659
0.32% 59
2018
Q2
$775M Buy
9,081,659
+30,857
+0.3% +$2.53M 0.27% 69
2018
Q1
$700M Buy
9,050,802
+187,506
+2% +$15.1M 0.25% 76
2017
Q4
$749M Sell
8,863,296
-733,533
-8% -$62.4M 0.27% 67
2017
Q3
$821M Hold
9,596,829
0.31% 60
2017
Q2
$790M Buy
9,596,829
+109,029
+1% +$8.89M 0.31% 58
2017
Q1
$798M Buy
9,487,800
+529,859
+6% +$42.4M 0.33% 52
2016
Q4
$659M Sell
8,957,941
-210,639
-2% -$15.7M 0.29% 66
2016
Q3
$703M Sell
9,168,580
-82,819
-0.9% -$6.63M 0.33% 52
2016
Q2
$729M Buy
9,251,399
+163,270
+2% +$12.3M 0.35% 52
2016
Q1
$654M Sell
9,088,129
-67,935
-0.7% -$5.14M 0.32% 57
2015
Q4
$771M Sell
9,156,064
-307,214
-3% -$25.5M 0.38% 49
2015
Q3
$792M Buy
9,463,278
+841,944
+10% +$71.1M 0.42% 43
2015
Q2
$720M Buy
8,621,334
+54,600
+0.6% +$4.16M 0.36% 49
2015
Q1
$622M Sell
8,566,734
-249,701
-3% -$17.8M 0.31% 61
2014
Q4
$608M Sell
8,816,435
-282,030
-3% -$19M 0.31% 61
2014
Q3
$590M Sell
9,098,465
-9,138,403
-50% -$579M 0.32% 59
2014
Q2
$1.13B Buy
18,236,868
+9,118,434
+100% +$544M 0.31% 63
2014
Q1
$537M Buy
9,118,434
+226,747
+3% +$12.7M 0.3% 65
2013
Q4
$453M Sell
8,891,687
-754,464
-8% -$37.8M 0.26% 73
2013
Q3
$485M Buy
9,646,151
+688,097
+8% +$36M 0.28% 68
2013
Q2
$440M Buy
+8,958,054
New +$487M 0.27% 71

Other funds holding LLY

Norges Bank's LLY Position: Q2 2026 in Review

Norges Bank opened a new position in Eli Lilly (LLY) in Q2 2026: 11,471,413 shares worth $13.8B. The stake represents 1.37% of the portfolio and ranks #11 among its holdings. This is a return to the name: Norges Bank previously reported a position in LLY as recently as Q4 2025.

Norges Bank first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Norges Bank held 11,471,413 shares of Eli Lilly worth $13.8B as of Q2 2026.
  • Eli Lilly was a new Norges Bank position in Q2 2026.
  • Eli Lilly made up 1.37% of Norges Bank's portfolio in Q2 2026, its #11 holding.
  • Norges Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.